Press Releases April 28, 2026 06:30 AM

Ducommun Incorporated Announces First Quarter Conference Call

Ducommun Announces Date for Q1 2026 Financial Results Release and Conference Call

By Caleb Monroe
Share
Twitter Reddit Facebook LinkedIn
DCO

Ducommun Incorporated, a manufacturer serving aerospace, defense, and industrial markets, announced it will release its first quarter 2026 financial results on May 12, 2026, before market open. The company's CEO and CFO will host a conference call and webcast to discuss the results and take questions.

Ducommun Incorporated Announces First Quarter Conference Call
DCO
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Scheduled release of Q1 2026 financial results on May 12, 2026.
  • Conference call to review results hosted by CEO Stephen G. Oswald and CFO Suman Mookerji.
  • Company operates in aerospace, defense, and industrial manufacturing sectors, focusing on electronic and structural systems.

COSTA MESA, Calif., April 28, 2026 (GLOBE NEWSWIRE) -- Ducommun Incorporated (NYSE: DCO) (“Ducommun” or the “Company”) today announced that it plans to release the Company's 2026 first quarter financial results on May 12, 2026, prior to the stock market opening. Stephen G. Oswald, the Company’s chairman, president and chief executive officer, and Suman Mookerji, the Company’s senior vice president and chief financial officer, will host a call that day at 10:00 a.m. PT (1:00 p.m. ET) to review these results.

To access the conference call, please pre-register using this registration link. Registrants will receive a confirmation with dial-in details. Mr. Oswald and Mr. Mookerji will speak on behalf of the Company and anticipate the meeting and Q&A period to last approximately 45 minutes. A live webcast of the event can be accessed using this link. A replay of the webcast will be available on the Ducommun website at www.ducommun.com.

About Ducommun Incorporated

Ducommun Incorporated delivers value-added innovative manufacturing solutions to customers in the aerospace, defense and industrial markets. Founded in 1849, the company specializes in two core areas – Electronic Systems and Structural Systems – to produce complex products and components for commercial aircraft platforms, mission-critical military and space programs, and sophisticated industrial applications. For more information, visit Ducommun.com



Risks

  • Potential for market volatility depending on Q1 financial performance results.
  • Dependence on aerospace and defense sectors which can be impacted by government budgets and economic conditions.
  • Exposure to industrial market fluctuations that may affect demand for complex manufacturing solutions.

More from Press Releases

Agios Showcases RISE UP Phase 3 Results at EHA 2026 Plenary Session Reinforcing Strong Anti-Hemolytic Profile of Mitapivat in Sickle Cell Disease Jun 13, 2026 Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026 Jun 13, 2026 Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema Jun 13, 2026 Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules Jun 12, 2026 Belite Bio Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease Type 1 Jun 12, 2026